Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

EC Vault Enters Global Deployment Phase, Introducing a Web2.5 + RWA On-Chain Treasury System

May 5, 2026

LBC Capital Income Fund Announces Planned Expansion of Asset-Backed Bridge Lending Into Major U.S. Metropolitan Markets

May 5, 2026

Latest Findings from DME AWARE Delphi Study Presented at ARVO 2026 Annual Meeting

May 5, 2026

Statkraft and SUNCATCHER agree on the marketing of three solar and battery storage facilities in Germany

May 5, 2026

2026 Sun Life Hong Kong International Dragon Boat Races Marks Dragon Boat Championship’s 50th Anniversary with the City’s Largest Day‑and‑night Hong Kong Dragon Boat Festival Across 13 Days This June

May 5, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Yalda Olcott, PharmD, Joins Noom as Head of Healthcare and Pharmacy Operations
Press Release

Yalda Olcott, PharmD, Joins Noom as Head of Healthcare and Pharmacy Operations

By News RoomOctober 1, 20244 Mins Read
Yalda Olcott, PharmD, Joins Noom as Head of Healthcare and Pharmacy Operations
Share
Facebook Twitter LinkedIn Pinterest Email

Noom Appoints Olcott to Advance Noom Med Programming Following Newly Launched GLP-1Rx Solution

NEW YORK, Oct. 01, 2024 (GLOBE NEWSWIRE) — Noom, the leading digital healthcare company committed to chronic disease prevention and empowering people to live better longer, is pleased to announce the appointment of Yalda Olcott, PharmD, as Head of Healthcare and Pharmacy Operations. Reporting to Noom’s Chief Medical Officer, Dr. Adonis Saremi, Olcott will lead the strategic implementation and management of the Noom Med program, including formulary design, ensuring operational efficiency and assisting with regulatory compliance. This role involves optimizing workflows, overseeing patient care quality, and collaborating with multidisciplinary teams to drive innovation and improve health outcomes.

Olcott brings over a decade of pharmacy leadership to Noom, including experiences in the retail pharmacy space, medication therapy management (MTM) and pharmacy benefits management (PBM). Her extensive PBM experience includes utilization management, formulary development, clinical program development and maintaining client relationships.

Most recently, Olcott held the role of VP Operations and Account Services at ClearScript. In this role, she led oversight and strategy of clinical programs, clinical services, product development, client relationships and vendor management. Previously at Prime Therapeutics, she was heavily involved in utilization management and medication therapy management, and maintaining client relationships while delivering cost-effective solutions for employers and health plans. She holds a Doctor of Pharmacy degree from North Dakota State University.

“I am ecstatic to join Noom during this critical time in healthcare because I believe in Noom’s mission to empower everyone, everywhere to live better longer,” said Yalda Olcott. “Noom’s approach to psychology-based weight management paired with improved medication access is a differentiator in the industry. I am looking forward to collaborating with the extraordinary team at Noom to combine my passion for health and wellness with my pharmacy experience to help people live healthier lives.”

In her role, Olcott will oversee Noom’s healthcare operations function as the company expands its offering with compounded GLP-1 injections alongside its powerful GLP-1 companion program, providing consumers not only affordable and accessible weight loss, but a sustainable pathway off the medications for those who do not wish to take them long-term.

“We could not be happier to have Yalda join our team during such a critical time for the business,” said Dr. Adonis Saremi, Chief Medical Officer at Noom. “Her dual expertise in clinical operations and account services across both B2B2C and B2B settings, as well as her experience managing drug formularies with an emphasis on GLP-1s, will provide a perfect complement to Noom’s holistic approach to weight loss, which ensures that our users not only receive the medications they need but also the behavioral and lifestyle support essential for long-term success.”

About Noom:

Noom is a digital healthcare company empowering everyone, everywhere to live better longer, through an unwavering commitment to innovation and whole-person health. Noom connects people to content, coaching, community, and clinicians to promote positive behavior and healthy habits, in an effort to promote healthspan and better living. Noom also works with leading health plans and employers offering Noom Med Center Of Excellence, Noom GLP-1 Companion, Noom Healthy Weight, and Noom Diabetes Prevention to millions of covered lives. The company has been awarded multiple grants from the National Institutes of Health and was the first mobile application to be recognized by the Centers for Disease Control and Prevention as a certified diabetes prevention program. With offices in New York City and Princeton, NJ, Noom has been named one of Inc.’s Best Places to Work, Quartz’s Best Workplaces for Remote Workers, and Fortune’s Best Workplaces in Technology. For more information, please visit noom.com, subscribe to our blog, or follow us on Twitter and LinkedIn.

Contact:
Brandyn Bissinger
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/2fe82854-4dbe-4927-9680-65e92b89b510

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

EC Vault Enters Global Deployment Phase, Introducing a Web2.5 + RWA On-Chain Treasury System

LBC Capital Income Fund Announces Planned Expansion of Asset-Backed Bridge Lending Into Major U.S. Metropolitan Markets

Latest Findings from DME AWARE Delphi Study Presented at ARVO 2026 Annual Meeting

Statkraft and SUNCATCHER agree on the marketing of three solar and battery storage facilities in Germany

2026 Sun Life Hong Kong International Dragon Boat Races Marks Dragon Boat Championship’s 50th Anniversary with the City’s Largest Day‑and‑night Hong Kong Dragon Boat Festival Across 13 Days This June

neurocare group AG announces MDMA approval of TMS Devices in Saudi Arabia

Gauth Expands Across Southeast Asia With Rollout of Live Tutor AI Learning Feature

Cytospire Therapeutics announces oversubscribed £61 million ($83m) Series A financing to advance pipeline of first-in-class pan-gamma delta T cell engagers into clinical trials for the treatment of cancer

Serious Allegations of Conflicts of Interest and Process Bias Emerge in Argyle Aquaculture Approval System

Editors Picks

LBC Capital Income Fund Announces Planned Expansion of Asset-Backed Bridge Lending Into Major U.S. Metropolitan Markets

May 5, 2026

Latest Findings from DME AWARE Delphi Study Presented at ARVO 2026 Annual Meeting

May 5, 2026

Statkraft and SUNCATCHER agree on the marketing of three solar and battery storage facilities in Germany

May 5, 2026

2026 Sun Life Hong Kong International Dragon Boat Races Marks Dragon Boat Championship’s 50th Anniversary with the City’s Largest Day‑and‑night Hong Kong Dragon Boat Festival Across 13 Days This June

May 5, 2026

Latest News

neurocare group AG announces MDMA approval of TMS Devices in Saudi Arabia

May 5, 2026

Gauth Expands Across Southeast Asia With Rollout of Live Tutor AI Learning Feature

May 5, 2026

Cytospire Therapeutics announces oversubscribed £61 million ($83m) Series A financing to advance pipeline of first-in-class pan-gamma delta T cell engagers into clinical trials for the treatment of cancer

May 5, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version